Brief: Recursion Presents Phase 2 Data For REC-994 in CCM
Feb 5 (Reuters) - Recursion Pharmaceuticals Inc
RXRX.O :
* RECURSION PRESENTS PHASE 2 DATA FOR REC-994 IN CCM IN
LATE-BREAKING ORAL PRESENTATION AT THE INTERNATIONAL STROKE
CONFERENCE
Source text: ID:nGNX76R7sN
Further company coverage: RXRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million